• For Researchers

It’s a fair COP: Why our chief clinician went to a climate change summit

Charlie Swanton, our chief clinician, headed to the world’s most important climate change conference to talk about the links between pollution and lung cancer in never smokers... Charlie Swanton, our chief clinician, headed to the world’s most important climate change conference to talk about the links between pollution and lung cancer in never smokers...

13 December 2021

• Health & Medicine

Over 600 people in England set to benefit from innovative lung cancer treatment

More than 600 people in England with a form of lung cancer could benefit from the innovative drug osimertinib (Tagrisso) after its approval by the National Institute for Health and Care Excellence. More than 600 people in England with a form of lung cancer could benefit from the innovative drug osimertinib (Tagrisso) after its approval by the National Institute for Health and Care Excellence.

1 December 2021

• Health & Medicine

Targeted drug recommended to treat some advanced lung cancer patients

Selpercatinib will expand treatment options available for people with RET fusion positive non small cell lung cancer on the NHS in England. Selpercatinib will expand treatment options available for people with RET fusion positive non small cell lung cancer on the NHS in England.

25 November 2021

• Health & Medicine

Three cancer drugs approved for NHS use in Scotland

Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected. Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected.

11 November 2021

• Health & Medicine

NHS lung cancer patients in England get early access to ‘breakthrough’ cancer drug

The Medicines and Healthcare products Regulatory Agency has approved the first-of-its-kind drug sotorasib for some people with non small cell lung cancer. The Medicines and Healthcare products Regulatory Agency has approved the first-of-its-kind drug sotorasib for some people with non small cell lung cancer.

10 September 2021

• Health & Medicine

Ground-breaking trial pilots new tests to detect lung cancer earlier

The first participants have taken part in a new research trial that aims to save lives by detecting lung cancer at an earlier stage when it is more treatable. The first participants have taken part in a new research trial that aims to save lives by detecting lung cancer at an earlier stage when it is more treatable.

16 June 2021

• Science & Technology
• Health & Medicine

ASCO 2021 news: follow-up treatments pave the way

One of the biggest meetings of the world’s cancer specialists took place this weekend. Here’s a flavour of the some of the top research presented. One of the biggest meetings of the world’s cancer specialists took place this weekend. Here’s a flavour of the some of the top research presented.

9 June 2021

• Health & Medicine

GPs report ‘perfect storm’ of problems leading to 20,000 drop in urgent referrals for lung cancer

Reluctance to attend hospital tests and come forward about symptoms could be contributing to delays in lung cancer diagnosis. Reluctance to attend hospital tests and come forward about symptoms could be contributing to delays in lung cancer diagnosis.

24 March 2021

• Health & Medicine

‘Thousands’ of lung cancer cases going undiagnosed in England

Health officials are urging people to get symptoms checked, after figures suggest that thousands of people in England could have undiagnosed lung cancer. Health officials are urging people to get symptoms checked, after figures suggest that thousands of people in England could have undiagnosed lung cancer.

17 February 2021

• Health & Medicine

Potentially life-extending treatment for lung cancer available in England

A potentially life-extending treatment for some people with non small cell lung cancer (NSCLC) will now be available on the NHS in England. A potentially life-extending treatment for some people with non small cell lung cancer (NSCLC) will now be available on the NHS in England.

9 February 2021

• Health & Medicine

Three new cancer drugs approved for NHS in Scotland

The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma. The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma.

21 January 2021

• Health & Medicine

COVID-19 referral drop fears for lung cancer patients in Wales

Confusion over the symptoms of lung cancer and COVID-19 may be responsible for a drop in the number of people being referred for lung cancer tests in Wales. Confusion over the symptoms of lung cancer and COVID-19 may be responsible for a drop in the number of people being referred for lung cancer tests in Wales.

20 November 2020